Acorah Software Products - Accounts Production 16.5.460 false true false true No description of principal activity 22 March 2024 31 March 2025 31 March 2025 15585139 Viktoriia Hlynchak iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15585139 2024-03-21 15585139 2025-03-31 15585139 2024-03-22 2025-03-31 15585139 frs-core:CurrentFinancialInstruments 2025-03-31 15585139 frs-bus:PrivateLimitedCompanyLtd 2024-03-22 2025-03-31 15585139 frs-bus:FilletedAccounts 2024-03-22 2025-03-31 15585139 frs-bus:Micro-entities 2024-03-22 2025-03-31 15585139 frs-bus:AuditExempt-NoAccountantsReport 2024-03-22 2025-03-31 15585139 frs-bus:Director1 2024-03-22 2025-03-31
Registered number: 15585139
Oasis Clinic Mcr Ltd
Unaudited Financial Statements
For the Period 22 March 2024 to 31 March 2025
Accountology Ltd
Oasis Clinic Mcr Ltd
Balance Sheet
As At 31 March 2025
Balance Sheet
Registered number: 15585139

| 31 March 2025
--- | ---
|  | £
Fixed assets |  | 23,755
Current assets |  | 8,714
Creditors: Amounts Falling Due Within One Year |  | (4,729 )
NET CURRENT ASSETS |  | 3,985
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 27,740
Accruals and deferred income |  | (845 )
NET ASSETS |  | 26,895
CAPITAL AND RESERVES |  | 26,895

## Notes

1. General Information
Oasis Clinic Mcr Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15585139 . The registered office is 232 Fog Lane, Manchester, M20 6EL.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Viktoriia Hlynchak Director
08/10/2025